Related Experiment Video

Updated: Jun 27, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of

Liang Cheng1, Shaobo Zhang, Gregory T MacLennan

  • 1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. liang_cheng@yahoo.com

Human Pathology
|November 26, 2008
PubMed

Insights

Molecular and cytogenetic techniques enhance understanding of renal cell carcinomas. These methods aid in diagnosis, prognosis, and therapy selection for diverse kidney cancers.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Renal cell carcinomas (RCCs) are a diverse group of kidney cancers with varied outcomes.
  • Understanding the molecular basis of RCCs is crucial for improving patient care.
  • Traditional classification methods do not fully capture the heterogeneity of these tumors.

Purpose of the Study:

  • To review molecular markers associated with different renal epithelial neoplasms.
  • To discuss the molecular mechanisms driving tumor initiation and progression in RCCs.
  • To evaluate the utility of molecular and cytogenetic techniques in RCC diagnosis, prognosis, and therapy.

Main Methods:

  • Review of current literature on molecular and cytogenetic studies in renal neoplasms.
  • Analysis of molecular alterations and their role in tumorigenesis.
  • Evaluation of diagnostic and prognostic applications of molecular techniques.

Main Results:

  • Molecular and cytogenetic analyses have significantly advanced the understanding of RCC biology.
  • Specific molecular markers are linked to distinct RCC subtypes and clinical behaviors.
  • These techniques offer improved accuracy in diagnosing challenging cases and predicting treatment response.

Conclusions:

  • Molecular classification provides new avenues for RCC diagnosis and personalized therapy.
  • Cytogenetic and molecular techniques are essential tools for accurate RCC assessment.
  • Further research into molecular mechanisms will refine prognostic models and therapeutic strategies for kidney cancers.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Related Concept Videos

Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Classification of Epithelial Tissues: Overview01:22

Classification of Epithelial Tissues: Overview

Epithelial tissues are classified according to the shape of the cells and the number of cell layers formed. Cell shapes can be squamous (flattened and thin), cuboidal (square-like, as wide as it is tall), or columnar (rectangular, taller than it is wide). Additionally, the nucleus shape helps identify the type of epithelial cells. Squamous cells have flattened disc-shaped nuclei, cuboidal cells have spherical nuclei, and columnar cells have elongated nuclei.
Based on the number of cell layers,...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...